These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9401764

  • 1. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.
    Schachter JB, Boyer JL, Li Q, Nicholas RA, Harden TK.
    Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764
    [Abstract] [Full Text] [Related]

  • 2. Identification of competitive antagonists of the P2Y1 receptor.
    Boyer JL, Romero-Avila T, Schachter JB, Harden TK.
    Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
    [Abstract] [Full Text] [Related]

  • 3. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
    Boyer JL, Lazarowski ER, Chen XH, Harden TK.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
    [Abstract] [Full Text] [Related]

  • 4. Expression of a cloned P2Y purinergic receptor that couples to phospholipase C.
    Filtz TM, Li Q, Boyer JL, Nicholas RA, Harden TK.
    Mol Pharmacol; 1994 Jul; 46(1):8-14. PubMed ID: 8058061
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
    Boyer JL, Zohn IE, Jacobson KA, Harden TK.
    Br J Pharmacol; 1994 Oct; 113(2):614-20. PubMed ID: 7834215
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
    Nicholas RA, Lazarowski ER, Watt WC, Li Q, Boyer J, Harden TK.
    J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
    [Abstract] [Full Text] [Related]

  • 7. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
    Schachter JB, Li Q, Boyer JL, Nicholas RA, Harden TK.
    Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of the response to purinergic agonists in P2Y1 transfected 1321N1 cells by antagonists suramin and PPADS.
    Brown CA, Charlton SJ, Boarder MR.
    Br J Pharmacol; 1997 Mar; 120(6):1049-52. PubMed ID: 9134216
    [Abstract] [Full Text] [Related]

  • 9. Characterisation of P2Y(1)-like receptor in cultured rat pineal glands.
    Ferreira ZS, Markus RP.
    Eur J Pharmacol; 2001 Mar; 415(2-3):151-6. PubMed ID: 11274993
    [Abstract] [Full Text] [Related]

  • 10. ADP-evoked phospholipase C stimulation and adenylyl cyclase inhibition in glioma C6 cells occur through two distinct nucleotide receptors, P2Y(1) and P2Y(12).
    Czajkowski R, Lei L, Sabała P, Barańska J.
    FEBS Lett; 2002 Feb 27; 513(2-3):179-83. PubMed ID: 11904146
    [Abstract] [Full Text] [Related]

  • 11. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
    Webb TE, Feolde E, Vigne P, Neary JT, Runberg A, Frelin C, Barnard EA.
    Br J Pharmacol; 1996 Dec 27; 119(7):1385-92. PubMed ID: 8968547
    [Abstract] [Full Text] [Related]

  • 12. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS, Dainty IA, McKay GD, Kirk IP, Humphries RG, Robertson MJ, Dougall IG, Leff P.
    Br J Pharmacol; 1998 May 27; 124(1):157-64. PubMed ID: 9630355
    [Abstract] [Full Text] [Related]

  • 13. Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7.
    Herold CL, Li Q, Schachter JB, Harden TK, Nicholas RA.
    Biochem Biophys Res Commun; 1997 Jun 27; 235(3):717-21. PubMed ID: 9207227
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of P2Y(11) receptor-mediated signalling to phospholipase C and adenylyl cyclase by protein kinase C in HL-60 promyelocytes.
    Suh BC, Kim TD, Lee IS, Kim KT.
    Br J Pharmacol; 2000 Oct 27; 131(3):489-97. PubMed ID: 11015299
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
    Mouawad R, Li Y, Anand-Srivastava MB.
    Mol Pharmacol; 2004 Apr 27; 65(4):917-24. PubMed ID: 15044621
    [Abstract] [Full Text] [Related]

  • 16. Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides.
    Kittner H, Franke H, Harsch JI, El-Ashmawy IM, Seidel B, Krügel U, Illes P.
    Eur J Neurosci; 2006 Oct 27; 24(7):2049-56. PubMed ID: 17067301
    [Abstract] [Full Text] [Related]

  • 17. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
    Jin J, Tomlinson W, Kirk IP, Kim YB, Humphries RG, Kunapuli SP.
    Br J Pharmacol; 2001 Jun 27; 133(4):521-8. PubMed ID: 11399669
    [Abstract] [Full Text] [Related]

  • 18. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
    Palmer RK, Boyer JL, Schachter JB, Nicholas RA, Harden TK.
    Mol Pharmacol; 1998 Dec 27; 54(6):1118-23. PubMed ID: 9855642
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of the human P2Y13 receptor.
    Marteau F, Le Poul E, Communi D, Communi D, Labouret C, Savi P, Boeynaems JM, Gonzalez NS.
    Mol Pharmacol; 2003 Jul 27; 64(1):104-12. PubMed ID: 12815166
    [Abstract] [Full Text] [Related]

  • 20. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
    Alvarado-Castillo C, Harden TK, Boyer JL.
    Mol Pharmacol; 2005 Jan 27; 67(1):114-22. PubMed ID: 15496502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.